These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38316854)

  • 21. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
    Gilbert TR; Noar A; Blalock O; Polonsky WH
    Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes.
    Chan CL
    Curr Diab Rep; 2017 Sep; 17(9):66. PubMed ID: 28726154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dawn phenomenon revisited: implications for diabetes therapy.
    Carroll MF; Schade DS
    Endocr Pract; 2005; 11(1):55-64. PubMed ID: 16033737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts.
    Oser TK; Litchman ML; Allen NA; Kwan BM; Fisher L; Jortberg BT; Polonsky WH; Oser SM
    Curr Diab Rep; 2021 Dec; 21(11):49. PubMed ID: 34882273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Comparison of Continuous Glucose Monitoring Estimated Hemoglobin A1c in Adults with Type 1 or Type 2 Diabetes.
    Salam M; Bailey R; Calhoun P; McGill JB; Bergenstal RM; Price D; Beck RW
    Diabetes Technol Ther; 2023 Mar; 25(3):178-185. PubMed ID: 36472504
    [No Abstract]   [Full Text] [Related]  

  • 26. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
    Ruedy KJ; Parkin CG; Riddlesworth TD; Graham C;
    J Diabetes Sci Technol; 2017 Nov; 11(6):1138-1146. PubMed ID: 28449590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial.
    Majithia AR; Kusiak CM; Armento Lee A; Colangelo FR; Romanelli RJ; Robertson S; Miller DP; Erani DM; Layne JE; Dixon RF; Zisser H
    J Med Internet Res; 2020 Aug; 22(8):e21778. PubMed ID: 32856597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous glucose monitoring in persons with type 2 diabetes not using insulin.
    Cowart K; Updike WH; Franks R
    Expert Rev Med Devices; 2021 Nov; 18(11):1049-1055. PubMed ID: 34633261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
    Pettus J; Edelman SV
    J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
    Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
    J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol.
    Zheng M; Luo Y; Lin W; Khoja A; He Q; Yang S; Zhao X; Hu P
    Syst Rev; 2020 May; 9(1):120. PubMed ID: 32475343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes Treated with Basal Insulin.
    Bao S; Bailey R; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 May; 24(5):299-306. PubMed ID: 34939824
    [No Abstract]   [Full Text] [Related]  

  • 37. Socioeconomic status and time in glucose target range in people with type 2 diabetes: a baseline analysis of the GP-OSMOTIC study.
    Tan ML; Manski-Nankervis JA; Thuraisingam S; Jenkins A; O'Neal D; Furler J
    BMC Endocr Disord; 2018 Jul; 18(1):47. PubMed ID: 30031385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of methods for detecting glycemic disorders.
    Bergman M; Abdul-Ghani M; DeFronzo RA; Manco M; Sesti G; Fiorentino TV; Ceriello A; Rhee M; Phillips LS; Chung S; Cravalho C; Jagannathan R; Monnier L; Colette C; Owens D; Bianchi C; Del Prato S; Monteiro MP; Neves JS; Medina JL; Macedo MP; Ribeiro RT; Filipe Raposo J; Dorcely B; Ibrahim N; Buysschaert M
    Diabetes Res Clin Pract; 2020 Jul; 165():108233. PubMed ID: 32497744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of a culturally tailored diabetes education curriculum with real-time continuous glucose monitoring in a Latinx population with type 2 diabetes: the CUT-DM with CGM for Latinx randomised controlled trial study protocol.
    Ehrhardt N; Cedeno B; Montour L; Sinclair K; Ferguson G; Berberian P; Comstock B; Wright L
    BMJ Open; 2023 Dec; 13(12):e082005. PubMed ID: 38154895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of dusk phenomenon on total glucose exposure in Chinese people with type 2 diabetes.
    Huang Y; Xu Y; Qiu J; Jiang C; Tan W; Tao X; Gu Q; Sun J
    Medicine (Baltimore); 2021 Apr; 100(13):e25298. PubMed ID: 33787619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.